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Abstract
DNA gyrase is a unique topoisomerase, which plays important roles in macromolecular events like DNA replication, transcription and
genetic recombination. In this study a high affinity monoclonal antibody to the gyrase B (GyrB) subunit of Mycobacterium smegmatis was
characterized, which did not cross-react with either the Escherichia coli GyrB subunit or with GyrB subunits from other mycobacterial
species. The antibody recognized an epitope in the N-terminus, novobiocin-binding domain of GyrB. Immunoprecipitation of gyrase from
M. smegmatis cell lysate revealed an association, mediated by ionic interactions, of gyrase A and GyrB subunits in the cell. This antibody is
a valuable tool for structure^function analysis and immunocytological studies of mycobacterial DNA gyrase. ß 2001 Federation of
European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Conformational and topological changes in DNA that
occur during many cellular processes such as replication,
transcription and recombination are mediated by a class of
enzymes known as DNA topoisomerases. Topoisomerases
are essential and ubiquitous enzymes necessary for the
viability of all organisms [1,2]. DNA gyrase is the only
enzyme which can introduce negative supercoiling in
DNA in an ATP dependent manner, and also perform
other topological interconversions of DNA such as knot-
ting/unknotting and catenation/decatenation [3]. DNA gy-
rase is well characterized from Escherichia coli and the
puri¢ed enzyme is composed of gyrase A (GyrA) and gy-
rase B (GyrB) subunits that form an A2B2 complex in
vitro. However, little information is available regarding
the oligomeric status of the enzyme in vivo. DNA gyrase
is essential for bacterial survival, and the enzyme is the
target of a number of antibacterial agents including qui-
nolones and coumarins [4].
The genus mycobacterium comprises several important
species of public health concern. Apart from Mycobacte-
rium tuberculosis and Mycobacterium leprae, the causative
agents of tuberculosis and leprosy, respectively, many oth-
er mycobacteria such as M. avium, M. kansasii, M. chelo-
nae and Mycobacterium fortuitum can cause opportunistic
infections in immunocompromised hosts [5]. The resur-
gence of tuberculosis and the emergence of highly virulent
multiple drug resistant M. tuberculosis clinical strains have
raised a global alarm. Biochemical studies of mycobacte-
rial DNA gyrase are still limited and poorly understood
and could aid in the design and development of gyrase as
a therapeutic target.
We have focussed our research e¡orts on structure^
function analysis of mycobacterial DNA gyrase, to ad-
dress the role of gyrase in important processes in myco-
bacteria. We have earlier cloned and over-expressed GyrA
and GyrB subunits from Mycobacterium smegmatis [6]. In
order to study the biochemical properties of the native
enzyme we have generated a monoclonal antibody
(mAb) to the GyrB subunit of M. smegmatis. This anti-
body reveals di¡erences in structure of GyrB from di¡er-
ent bacterial species, and also provides evidence for the
¢rst time that mycobacterial GyrB subunit exists in asso-
ciation with the GyrA in vivo.
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2. Materials and methods
2.1. Bacterial strains, plasmids and materials
M. smegmatis SN2 was a laboratory strain, M. tuber-
culosis H37Rv was obtained from National Tuberculosis
Institute, Bangalore, India. M. fortuitum and Mycobacte-
rium gilvum were provided by Dr. V.M. Katoch, Central
JALMA Institute for Leprosy, Agra, India. All mycobac-
terial species were grown in modi¢ed Youmans and Karl-
son’s medium as described earlier [7].
2.2. Expression and puri¢cation of recombinant gyrase
subunits
For the puri¢cation of M. smegmatis GyrB, E. coli
strain BL21(DE3)pLysS harboring the recombinant plas-
mid pMK25 [6] was grown in Luria Bertani broth and the
cells were induced with 500 WM isopropylthio-L-D-galacto-
side (IPTG) for 3 h at 18‡C. Cells were lysed by sonication
in bu¡er (20 mM Tris pH 8.0, 1 mM EDTA, 10% glycerol,
5 mM L-mercaptoethanol, 1 mM phenyl methyl sulfonyl
£uoride, 1 mM benzamidine HCl and 1% Triton X-100).
The cell lysate was centrifuged at 40 000 rpm and the
supernatant treated with ammonium sulfate to obtain a
30^55% pellet fraction. The pellet was solubilized in
TGEM bu¡er (50 mM Tris pH 7.6, 10% glycerol, 2 mM
EDTA and 2 mM L-mercaptoethanol) and subjected to
puri¢cation on MonoQ and Heparin Sepharose columns
(Amersham-Pharmacia Biotech) using 0^1 M NaCl gra-
dient elution. GyrB protein was eluted at 300 mM NaCl
gradient. M. tuberculosis GyrB was over-expressed in
BL21(DE3)pLysS cells harboring pMK15 and puri¢ed
by electroelution from preparative sodium dodecyl sulfate
(SDS)^polyacrylamide gels. Recombinant E. coli GyrA
was puri¢ed as previously described by Maxwell and Ho-
wells [8]. The polyclonal antibodies were raised against
puri¢ed M. tuberculosis recombinant GyrA and GyrB pro-
teins in rabbits [9].
2.3. Generation of anti-GyrB mAb
Balb/c mice were immunized intradermally with 100 Wg
of M. smegmatis GyrB, and mAbs generated as previously
described [10]. Enzyme-linked immunosorbent assay was
performed using M. smegmatis GyrB (2 Wg ml31) as de-
scribed earlier [9]. An antibody-secreting clone, MsGyr-
B:A4, was subcloned to monoclonality by limiting dilu-
tion. Ascites £uid was prepared by intraperitoneal
injection of 1U106 hybridoma cells into Balb/c mice. Im-
munoglobulins were puri¢ed from ascitic £uid using Pro-
tein-A Sepharose a⁄nity column chromatography and iso-
typed as IgG1 with U light chain.
Fab fragments of the IgG were prepared by papain
digestion of the puri¢ed immunoglobulin and puri¢ed by
Protein-A Sepharose a⁄nity column. For Western blot
analysis, proteins were resolved on an 8% SDS^PAGE
[11]. Proteins were transferred to polyvinylidene di£uoride
membrane in transfer bu¡er (50 mM Tris^glycine bu¡er,
pH 8.5, containing 20% methanol). The membrane was
blocked with phosphate-bu¡ered saline containing 2% bo-
vine serum albumin and probed with polyclonal antiserum
either to GyrA (1:20 000) or GyrB (1:12 000) or mAb
MsGyrB:A4 (0.1 Wg ml31). Bound IgG was detected using
anti-rabbit or anti-mouse IgG conjugated to horseradish
peroxidase and enhanced chemiluminescence reagents
(Amersham-Pharmacia Biotech).
2.4. Immunoprecipitation of gyrase from mycobacterial
cell-free extracts
Cell-free extracts were prepared from mycobacterial cul-
tures grown to mid-exponential phase. Protein was esti-
mated by the method of Bradford [12]. Protein (500 Wg)
was pre-incubated with 200 Wg ml31 of anti-GyrB poly-
clonal antibodies or 50 Wg ml31 of MsGyrB:A4 or normal
mouse immunoglobulin in immunoprecipitation (IP) bu¡-
er (50 mM Tris pH 7.4, 1 mM EDTA, 5 mM L-mercap-
toethanol, 50 mM NaCl, 1% Nonidet P-40 and 5% glyc-
erol) for 6 h at 4‡C. For immunoprecipitation under high
salt conditions, MsGyrB:A4 (50 Wg ml31) was pre-incu-
bated with cell lysate (500 Wg) in IP bu¡er containing 500
mM NaCl. The immunocomplex was recovered by adding
10 Wl of Protein G agarose and incubation continued for
1 h. Immunocomplexes were washed and analyzed by
SDS^PAGE followed by silver staining of the gel and
Western blotting.
2.5. Novobiocin interaction with GyrB bound to
MsGyrB:A4
Novobiocin was coupled to epoxy-activated Sepharose
6B as described earlier [13]. GyrB protein (1 Wg) was in-
cubated in the absence or presence of 100 Wg of novobio-
cin at 37‡C for 1 h in 50 Wl of IP bu¡er followed by the
addition of MsGyrB:A4 (3 Wg). Incubation was continued
for a further 1 h and the protein complex then recovered
by addition of either 10 Wl of Protein G agarose or novo-
biocin Sepharose (15 Wl). The beads were washed with IP
bu¡er extensively, followed by analysis by SDS^PAGE
and Western blotting.
2.6. Generation of truncated GyrB protein
To generate the N-terminal M. smegmatis GyrB clone
encoding 1^270 amino acids, oligonucleotide primers for
PCR ampli¢cation (FP-CGTCGCCATGGCTGCCCAG-
AAG and RP-CTTGACGAATTCGACCAGACCACCC)
were designed with an NcoI site in the 5P primer. The PCR
product obtained with pMN6A [6] as template was di-
gested with NcoI and EcoRI and cloned into pTrc99C
predigested with NcoI and EcoRI to obtain pMsGyrB:vC
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plasmid. pMsGyrB:vC was transformed in E. coli DH10b
cells and induced with IPTG at an optical density of 0.6
(A600).
2.7. Surface plasmon resonance (SPR) spectroscopy
Binding kinetics were determined by SPR spectroscopy
[14] using a BIAcore 2000 system, Uppsala, Sweden. The
over-expressed and puri¢ed M. smegmatis GyrB was im-
mobilized on the CM5 sensor chip at a concentration of
1200 resonance units as per manufacturer’s instructions.
All measurements were carried out in a continuous £ow
of HBS bu¡er (10 mM HEPES, 150 mM NaCl, 5 mM
EDTA and 0.05% Surfactant P-20, pH 7.4). The kinetic
data were analyzed using the BIA evaluation software
(Version 3.0). The surface was regenerated by a pulse of
5 Wl of 10 mM NaOH, for further experimentation as
required.
3. Results
3.1. Epitope speci¢city in mycobacterial GyrB subunit
Western blot analysis using polyclonal antibodies raised
against M. tuberculosis GyrB subunit was performed with
puri¢ed proteins from M. tuberculosis, M. smegmatis and
Fig. 1. Species speci¢c cross-reactivity of anti-GyrB antibodies. (A)
Western blot analysis of GyrB proteins (1 Wg per lane) puri¢ed from M.
smegmatis, M. tuberculosis and E. coli was performed with a polyclonal
antibody raised against M. tuberculosis GyrB. (B) Cell lysates were incu-
bated with 200 Wg ml31 IgG puri¢ed from the polyclonal antiserum or
50 Wg ml31 MsGyrB:A4 in IP bu¡er. Immunocomplexes were recovered
using 10 Wl of Protein G agarose. Immunoprecipitates were analyzed by
SDS^PAGE and Western blot was performed with polyclonal antibody
or MsGyrB:A4.
Fig. 2. (A) A pair-wise amino acid sequence alignment of GyrB of M.
smegmatis (MsGyrB, X84077) [6] and M. tuberculosis (MtbGyrB,
X78888) [23]. The alignment was obtained using GCG software. (B)
Epitope mapping of MsGyrB:A4 mAb using GyrB truncated protein.
(i) Schematic representation of M. smegmatis GyrB proteins. (ii) Immu-
noblot analysis of truncated M. smegmatis GyrB protein. Extracts pre-
pared from E. coli cells harboring plasmid pMsGyrB:vC with or with-
out induction with IPTG were analyzed on SDS^PAGE and Western
blotting performed with MsGyrB:A4. Lane 1 contains 0.5 Wg of puri¢ed
M. smegmatis GyrB.
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E. coli, and results indicated that all the three proteins
were recognized (Fig. 1A). Interestingly, the mAb MsGyr-
B:A4 immunoprecipitated GyrB from M. smegmatis SN2
cell lysate but not from M. tuberculosis H37Rv cell lysate
(Fig. 1B), whereas the GyrB speci¢c polyclonal antibody
immunoprecipitated GyrB from both the cell lysates.
MsGyrB:A4 showed no reactivity with other fast growing
mycobacterial species, i.e. M. fortuitum and M. gilvum
(data not shown). The GyrB subunits of M. smegmatis
and M. tuberculosis share an overall 88% identity at the
amino acid level, but the observation that MsGyrB:A4
reacts with M. smegmatis GyrB alone indicates that this
mAb binds to a unique region present in M. smegmatis
protein.
Considerable di¡erences in the amino acid sequences of
M. smegmatis and M. tuberculosis are observed in the N-
terminal region (Fig. 2A), where there is only 77% identity
in the sequences of M. smegmatis and M. tuberculosis from
residues 1 to 260, as opposed to 93% identity in the C-
terminal region of the protein. It is therefore possible that
MsGyrB:A4 interacts with the N-terminus of M. smegma-
tis GyrB. To con¢rm this, the N-terminal 1^259 amino
acids of GyrB were over-expressed in E. coli, and Western
blot analysis was performed with bacterial lysates pre-
pared from cells expressing the truncated GyrB subunit.
As shown in Fig. 2B, the epitope for MsGyrB:A4 lies in
the N-terminus of M. smegmatis GyrB.
The amino-terminal of E. coli GyrB 2^220 amino acids,
a 24-kDa protein, binds coumarins, and this fragment has
been crystallized with novobiocin [15]. Since both novo-
biocin and MsGyrB:A4 interact with the N-terminus of
GyrB, we tested whether the interaction of novobiocin
with GyrB modulated mAb-binding. M. smegmatis GyrB
was pre-incubated with novobiocin, followed by the addi-
tion of MsGyrB:A4 mAb. The protein complex was then
recovered with either Protein G agarose or novobiocin
Sepharose (Fig. 3). Novobiocin bound GyrB could inter-
act with MsGyrB:A4 (Fig. 3, lane 5). Pre-incubation of
GyrB protein with novobiocin completely inhibited further
interaction with novobiocin Sepharose (Fig. 3, lane 4),
indicating that all the GyrB was bound to novobiocin
under these experimental conditions. MsGyrB:A4 bound
to GyrB complex could be precipitated with novobiocin
Sepharose (Fig. 3, lane 3), indicated by the presence of the
heavy and light chains of the antibody associated with the
novobiocin Sepharose. MsGyrB:A4 antibody did not bind
to novobiocin Sepharose in the absence of GyrB protein
(data not shown). These results therefore indicate that
binding sites for novobiocin and mAb do not overlap
with each other, and binding of novobiocin to GyrB
does not preclude binding of the antibody simultaneously.
Fig. 3. Analysis of interaction of MsGyrB:A4 and novobiocin with
GyrB. Puri¢ed M. smegmatis GyrB was pre-incubated without (lanes
1^3) or with 100 Wg of novobiocin (lanes 4 and 5) at 37‡C for 1 h fol-
lowed by addition of 3 Wg of MsGyrB:A4 (lanes 2, 3 and 5). The com-
plexes were isolated using novobiocin Sepharose (lanes 1, 3 and 4) or
Protein G agarose (lanes 2 and 5). The precipitates were subjected to
SDS^PAGE and Western blot analysis with MsGyrB:A4.
Fig. 4. Immunoprecipitation of DNA gyrase with MsGyrB:A4. Extracts
prepared from M. smegmatis SN2 (500 Wg) were incubated with 5 Wg of
MsGyrB:A4 (lane 1) or normal mouse IgG (lane 2) in IP bu¡er. The
immunocomplexes were precipitated using Protein G agarose and ana-
lyzed by SDS^PAGE. A similar immunoprecipitation was performed
with MsGyrB:A4 in IP bu¡er containing 500 mM NaCl (lane 3). The
crude cell lysate (10 Wg per lane) and protein molecular mass markers
are shown in lanes L and M, respectively. The gel was subjected to sil-
ver staining (panel A) or Western blotting with GyrA (panel B) or
GyrB (panel C) speci¢c polyclonal antibodies. GyrA polypeptide showed
a characteristic proteolytic degradation to a protein fragment of 78 kDa
[24].
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3.2. Interaction of MsGyrB:A4 with DNA gyrase
The a⁄nity of the mAb for M. smegmatis GyrB was
determined by analysis of the binding kinetics by biosen-
sor studies [14]. Analysis of the data obtained allowed the
determination of kinetic constants of interaction and in-
dicated that MsGyrB:A4 displayed a high a⁄nity interac-
tion (KD 3.4U1039 M) with GyrB subunit.
The E. coli gyrase is a heterotetramer comprising GyrA
and GyrB polypeptides [2,3]. The DNA gyrase from
Mycobacterium bovis has been shown to form GyrA^B
complex when individual subunits are reconstituted onto
DNA [16]. In order to determine if the mycobacterial en-
zyme also exists as a complex of GyrA and GyrB subunits
in the cell, the cell lysate was treated with mAb and anti-
body bound enzyme collected with Protein G agarose. The
immunoprecipitate was analyzed by SDS^PAGE followed
by silver staining (Fig. 4A). MsGyrB:A4 speci¢cally
immunoprecipitated two polypeptides, which reacted
with their speci¢c antibodies on Western blot analysis
(Fig. 4B,C). When immunoprecipitation was performed
in the presence of 500 mM NaCl, no GyrA polypeptide
was found in the immunoprecipitate (Fig. 4, lane 3), in-
dicating GyrA^GyrB interaction is predominantly ionic in
nature.
4. Discussion
To generate speci¢c probes for the structure^func-
tion analysis of mycobacterial DNA gyrase, a mAb to
M. smegmatis GyrB subunit was generated. The studies
reported here are the ¢rst to describe the development
and characterization of mAb to any mycobacterial DNA
GyrB subunit.
The type II topoisomerase family, which includes topo-
isomerase II of bacteriophage, eubacteria as well as eu-
karyotic enzymes, shares strong similarities in enzymatic
properties and protein primary sequences [17]. We have
however earlier noted a major di¡erence in the amino
acid sequence at the C-terminus of Gram-positive and
Gram-negative bacterial GyrB, where a contiguous stretch
of 165 amino acids is missing from Gram-positive bacteria
[18]. While many epitopes in the protein are conserved, as
shown by the cross-reactivity of polyclonal antibodies to
M. tuberculosis GyrB with the E. coli enzyme (Fig. 1A), it
is apparent that certain variations are located in the se-
quences at the N-terminus of the GyrB subunit, as de-
tected by the extraordinary speci¢city of MsGyrB:A4
(Fig. 1B).
Earlier workers have proposed that GyrB could be a
suitable phylogenetic marker for the identi¢cation and
classi¢cation of bacteria [19]. These GyrB-based methods
have already shown to be useful for the di¡erentiation of
closely related strains of Vibrio and Bacillus. Sequence
analysis of the mycobacterial GyrB subunit has shown
that more substitutions are found in the GyrB sequence
than in 16S rDNA [20]. Since MsGyrB:A4 appears to
distinguish between M. smegmatis and other strains of
mycobacteria, this antibody could be used to characterize
closely related strains of mycobacteria. It is therefore con-
ceivable that mAbs speci¢c to M. tuberculosis or M. leprae
GyrB proteins could also be generated for rapid diagnosis
of mycobacterial infections.
The 43-kDa amino-terminal domain of E. coli GyrB
possesses a coumarin-sensitive ATPase activity, thereby
localizing the coumarin drug-binding site to this part of
the protein. The 43-kDa domain folds as two sub-do-
mains, the amino-terminal 220 amino acids form the ¢rst
domain which has been crystallized with novobiocin and
the structure solved to high resolution [15] and amino
acids 221^392 the second [21]. Since gyrase from mycobac-
teria was puri¢ed by novobiocin a⁄nity chromatography
[13], it can be concluded that the overall structure in the
N-terminus of M. smegmatis GyrB is similar to that of
E. coli enzyme. Even though MsGyrB:A4 interacts with
the N-terminal domain of M. smegmatis protein, its inter-
action was not a¡ected by novobiocin-binding to the
GyrB subunit (Fig. 3), implying that the binding sites of
novobiocin and the antibody are distinct.
The 47-kDa C-terminal domain of E. coli GyrB inter-
acts with the DNA and GyrA subunit [3]. MsGyrB:A4
immunoprecipitates both GyrB and GyrA polypeptides
(Fig. 4), indicating that the regions of interaction of
GyrB with mAb and GyrA are distinct from each other.
This would perhaps imply that the GyrA- and DNA-bind-
ing regions are located in the carboxy-terminal of GyrB,
which is similar to the domain organization of E. coli
GyrB.
Based on immunolocalization studies in E. coli [22], it
was suggested that the GyrA and GyrB proteins are
present within the cytoplasm as discrete subunits, which
may or may not be DNA-associated. Till date, no infor-
mation is available on the nature of the gyrase holoen-
zyme in mycobacterial cells. Our immunoprecipitation
studies with the cell-free extracts reveal that at least in
M. smegmatis, a signi¢cant amount of association of
GyrA and GyrB subunits is observed, perhaps represent-
ing the fraction of active holoenzyme. This mAb would
therefore be an ideal tool for immunolocalization studies
of the holoenzyme or holoenzyme DNA complex in
M. smegmatis. The interaction of GyrA and GyrB sub-
units is inhibited by the presence of sodium chloride, as
shown by co-immunoprecipitation studies, indicating that
predominantly ionic interactions are critical in mediating
association of the two subunits.
Since MsGyrB:A4 speci¢cally immunoprecipitated both
subunits of gyrase, the mAb could be used as a ligand for
the immunoa⁄nity puri¢cation of individual subunits of
mycobacterial DNA gyrase. Our observation that GyrA^
GyrB interaction can be disrupted with 500 mM NaCl
should allow speci¢c elution of the individual subunits,
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thereby allowing a detailed biochemical characterization
of this complex enzyme from mycobacteria.
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